International Companies

Gilead Sciences to snap up Arcellx in near $8bn deal

By Abigail Townsend

Date: Monday 23 Feb 2026

(Sharecast News) - Shares in Arcellx soared on Monday, after the US biotech agreed to be taken over by Gilead Sciences in a near $8bn deal.
Under the terms of the deal, California-based Gilead will pay $115 per share in cash and one contingent value of $5 per share, giving Arcellx...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page